Literature DB >> 16914838

Characteristics of the binding of thioflavin S to tau paired helical filaments.

Ismael Santa-María1, Mar Pérez, Félix Hernández, Jesús Avila, Francisco J Moreno.   

Abstract

Binding of histological benzothiazole dye thioflavin S (ThS) to protein aggregates has been related with the presence of amyloid beta sheet structure in those protein aggregates. Paired helical filaments (PHF) from Alzheimer's disease (AD) patients, (whose main component is the microtubule associated protein, tau) bind to thioflavins. By using a novel immunofluorescence method, the binding of ThS to isolated tau filaments was tested. Also, the characteristics of this binding of ThS to PHF or to the in vitro assembled tau filaments, have been analyzed. Our results suggests that ThS binds to PHF with a higher affinity than to the straight filaments (SF), also found in AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16914838     DOI: 10.3233/jad-2006-9307

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  22 in total

1.  Pseudohyperphosphorylation has differential effects on polymerization and function of tau isoforms.

Authors:  Benjamin Combs; Kellen Voss; T Chris Gamblin
Journal:  Biochemistry       Date:  2011-10-17       Impact factor: 3.162

2.  Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease.

Authors:  Leonel E Rojo; Jans Alzate-Morales; Iván N Saavedra; Peter Davies; Ricardo B Maccioni
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  A novel tau mutation, p.K317N, causes globular glial tauopathy.

Authors:  Pawel Tacik; Michael DeTure; Wen-Lang Lin; Monica Sanchez Contreras; Aleksandra Wojtas; Kelly M Hinkle; Shinsuke Fujioka; Matthew C Baker; Ronald L Walton; Yari Carlomagno; Patricia H Brown; Audrey J Strongosky; Naomi Kouri; Melissa E Murray; Leonard Petrucelli; Keith A Josephs; Rosa Rademakers; Owen A Ross; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-04-22       Impact factor: 17.088

4.  Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs.

Authors:  A B Rocher; J L Crimins; J M Amatrudo; M S Kinson; M A Todd-Brown; J Lewis; J I Luebke
Journal:  Exp Neurol       Date:  2009-08-07       Impact factor: 5.330

5.  In vitro aggregation assays using hyperphosphorylated tau protein.

Authors:  Dexin Sui; Mengyu Liu; Min-Hao Kuo
Journal:  J Vis Exp       Date:  2015-01-02       Impact factor: 1.355

6.  Proteopathic tau seeding predicts tauopathy in vivo.

Authors:  Brandon B Holmes; Jennifer L Furman; Thomas E Mahan; Tritia R Yamasaki; Hilda Mirbaha; William C Eades; Larisa Belaygorod; Nigel J Cairns; David M Holtzman; Marc I Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-26       Impact factor: 11.205

7.  Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies.

Authors:  Adriana Ferreira; Eileen H Bigio
Journal:  Mol Med       Date:  2011-03-21       Impact factor: 6.354

8.  Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells.

Authors:  Marija Usenovic; Shahriar Niroomand; Robert E Drolet; Lihang Yao; Renee C Gaspar; Nathan G Hatcher; Joel Schachter; John J Renger; Sophie Parmentier-Batteur
Journal:  J Neurosci       Date:  2015-10-21       Impact factor: 6.167

9.  The influence of phospho-τ on dendritic spines of cortical pyramidal neurons in patients with Alzheimer's disease.

Authors:  Paula Merino-Serrais; Ruth Benavides-Piccione; Lidia Blazquez-Llorca; Asta Kastanauskaite; Alberto Rábano; Jesús Avila; Javier DeFelipe
Journal:  Brain       Date:  2013-05-28       Impact factor: 13.501

10.  Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau.

Authors:  Ismael Santa-Maria; Félix Hernández; Joaquín Del Rio; Francisco J Moreno; Jesús Avila
Journal:  Mol Neurodegener       Date:  2007-09-06       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.